Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia. This evidence concerns the gene ARID5B and chronic myelogenous leukemia, BCR-ABL1 positive.